JP2008505060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008505060A5 JP2008505060A5 JP2007513872A JP2007513872A JP2008505060A5 JP 2008505060 A5 JP2008505060 A5 JP 2008505060A5 JP 2007513872 A JP2007513872 A JP 2007513872A JP 2007513872 A JP2007513872 A JP 2007513872A JP 2008505060 A5 JP2008505060 A5 JP 2008505060A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- slc6a3
- gene
- polymorphism
- vntr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57713104P | 2004-06-04 | 2004-06-04 | |
| PCT/EP2005/006002 WO2005118848A1 (en) | 2004-06-04 | 2005-06-03 | Biomarkers for the prediction of responsiveness to clozapine treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008505060A JP2008505060A (ja) | 2008-02-21 |
| JP2008505060A5 true JP2008505060A5 (enExample) | 2008-07-24 |
Family
ID=34970966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007513872A Pending JP2008505060A (ja) | 2004-06-04 | 2005-06-03 | クロザピン処置に対する応答を予測するためのバイオマーカー |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090281090A1 (enExample) |
| EP (1) | EP1756314A1 (enExample) |
| JP (1) | JP2008505060A (enExample) |
| CN (1) | CN1973051A (enExample) |
| AU (1) | AU2005250142B2 (enExample) |
| BR (1) | BRPI0510775A (enExample) |
| CA (1) | CA2568729A1 (enExample) |
| MX (1) | MXPA06014127A (enExample) |
| RU (1) | RU2006146207A (enExample) |
| WO (1) | WO2005118848A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100129818A1 (en) * | 2007-04-30 | 2010-05-27 | The Ohio State University Research Foundation | Polymorphisms in Genes Affecting CYP2C9-Related Disorders and Uses Thereof |
| US7932042B1 (en) | 2010-10-13 | 2011-04-26 | Suregene, Llc | Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature |
| US20130029862A1 (en) * | 2011-06-02 | 2013-01-31 | Gareth Davies | Clinical application utilizing genetic data for effective medication management |
| EP2883052B8 (en) | 2012-08-10 | 2019-03-13 | Istituto Superiore di Sanità | Biomarkers |
| CN112195230B (zh) * | 2020-09-17 | 2022-08-23 | 青岛大学附属医院 | 一种用于氯氮平个体化用药指导的基因检测试剂、试剂盒、检测方法及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2381525A (en) * | 2001-11-01 | 2003-05-07 | Tcs Cellworks Ltd | Regulating gene expression |
| AU2003207989A1 (en) * | 2002-02-21 | 2003-09-09 | Idgene Pharmaceuticals Ltd. | Association of snps in the comt locus and neighboring loci with schizophrenia, bipolar disorder, breast cancer and colorectal cancer |
| AU2003231897A1 (en) * | 2002-06-03 | 2003-12-19 | Idgene Pharmaceuticals Ltd. | Association of snps in the dgcr2 locus and neighboring loci with schizophrenia |
| US20070065821A1 (en) * | 2003-02-21 | 2007-03-22 | Sridhar Kudaravalli | Methods for the prediction of suicidality during treatment |
-
2005
- 2005-06-03 RU RU2006146207/13A patent/RU2006146207A/ru not_active Application Discontinuation
- 2005-06-03 WO PCT/EP2005/006002 patent/WO2005118848A1/en not_active Ceased
- 2005-06-03 BR BRPI0510775-0A patent/BRPI0510775A/pt not_active IP Right Cessation
- 2005-06-03 US US11/571,001 patent/US20090281090A1/en not_active Abandoned
- 2005-06-03 MX MXPA06014127A patent/MXPA06014127A/es not_active Application Discontinuation
- 2005-06-03 JP JP2007513872A patent/JP2008505060A/ja active Pending
- 2005-06-03 EP EP05754261A patent/EP1756314A1/en not_active Withdrawn
- 2005-06-03 AU AU2005250142A patent/AU2005250142B2/en not_active Ceased
- 2005-06-03 CA CA002568729A patent/CA2568729A1/en not_active Abandoned
- 2005-06-03 CN CNA2005800178554A patent/CN1973051A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010507388A5 (enExample) | ||
| EP3507384B1 (en) | Methods and composition for the prediction of the activity of enzastaurin | |
| JP2014533949A5 (enExample) | ||
| Hsu et al. | Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma | |
| JP2010522555A5 (enExample) | ||
| JP2011530306A5 (enExample) | ||
| JP2011520433A5 (enExample) | ||
| RU2009147281A (ru) | Способы и композиции для диагностики и лечения волчанки | |
| JP2013507127A5 (enExample) | ||
| EP3954784A1 (en) | Composition for diagnosis or prognosis prediction of glioma, and method for providing information related thereto | |
| Sanada et al. | Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade | |
| WO2016025602A1 (en) | Allelic polymorphisms associated with reduced risk for alzheimer's disease | |
| CN111560428B (zh) | 检测线粒体DNA rs3937033单核苷酸多态性的物质的用途 | |
| JP2010510804A5 (enExample) | ||
| CN112424381A (zh) | 包括arhgap32基因单碱基多态性的脑动脉瘤诊断用snp标志物 | |
| KR20200100614A (ko) | 유방암 발생의 위험도 평가의 방법 | |
| KR101761801B1 (ko) | 코 표현형 판단용 조성물 | |
| JP5226256B2 (ja) | 加齢黄斑変性症の発症リスクの予測方法 | |
| JP5721150B2 (ja) | 加齢黄斑変性症の発症リスクの予測方法 | |
| JP2008505060A5 (enExample) | ||
| EP3938531A1 (en) | Methods for detecting or reducing the incidence of adverse drug reactions | |
| KR101819795B1 (ko) | 대장암 발병 진단 및 예측용 유전 마커 | |
| RU2006146207A (ru) | Биомаркеры для предсказания чувствительности к лечению клозапином | |
| KR102883401B1 (ko) | 우울증 진단용 단일염기다형성 및 이의 용도 | |
| KR101757108B1 (ko) | 전장유전체연관분석방법을 이용한 단일염기다형성에 의한 심방세동의 예측 또는 진단에 관한 정보 제공 방법 |